| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/13/2003 | WO2003011008A2 Therapeutic delivery compositions and methods of use thereof |
| 02/13/2003 | WO2003004016A8 Use of substituted gamma-lactone compounds as medicaments |
| 02/13/2003 | WO2002096457A3 Stable liquid formulations of antibodies |
| 02/13/2003 | WO2002090363A8 ANHYDROUS CRYSTAL OF ss-LACTAM COMPOUND AND METHOD FOR PREPARATION THEREOF |
| 02/13/2003 | WO2002088328A8 Method for generating highly active human dendritic cells from monocytes |
| 02/13/2003 | WO2002083657A3 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 02/13/2003 | WO2002077007A3 Novel polyaminated fusidic acid derivatives |
| 02/13/2003 | WO2002076995A3 2-amino-propanol derivatives |
| 02/13/2003 | WO2002066067A3 Albumin-based drug delivery system and antimicrobial peptides |
| 02/13/2003 | WO2002062810A3 Linkable sialyl lewis x analogs |
| 02/13/2003 | WO2002060482A3 Perylenequinones for use with immunotherapy agents |
| 02/13/2003 | WO2002051434A3 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 02/13/2003 | WO2002046192A3 Thioether substituted imidazoquinolines |
| 02/13/2003 | WO2002040462A3 Cysteine protease inhibitors |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | WO2001087286A3 Antisense enzyme inhibitors for improving pharmacokinetics of a drug |
| 02/13/2003 | WO2001070772A3 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of an addition salt to an acid |
| 02/13/2003 | US20030032995 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 02/13/2003 | US20030032804 Methods of treating periodontal disease |
| 02/13/2003 | US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase |
| 02/13/2003 | US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders |
| 02/13/2003 | US20030032772 Peptide for use in the diagnosis and prevention of immunological and infectious disorders |
| 02/13/2003 | US20030032678 Comprises plant extracts/oils (isopropyl-o-cresol) reacted with sodium chloride to form sodium-o-cresolate, to provide antimicrobial function |
| 02/13/2003 | US20030032654 Useful for the treatment or prevention of asthma and other allergic diseases. |
| 02/13/2003 | US20030032652 Hydroxamic and carboxylic acid derivatives |
| 02/13/2003 | US20030032630 Use of a 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kappaB |
| 02/13/2003 | US20030032626 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 02/13/2003 | US20030032612 Inhibit expression of a gene in the operon; reducing bacterial resistance to antibiotics |
| 02/13/2003 | US20030032600 Taste masked liquid pharmaceutical compositions |
| 02/13/2003 | US20030032599 Inhibiting growth or survival of a microorganism, comprising directly contacting the microorganism with a substance P peptide or a peptide mimetic thereof. |
| 02/13/2003 | US20030032596 Administering a compound that modulates the synthesis or expression of a target cellular gene, especially a Src kinase. |
| 02/13/2003 | US20030032593 Transporters comprising spaced arginine moieties |
| 02/13/2003 | US20030032584 Inhibiting abnormal cellular proliferation in a mammal; and a method of inhibiting replication of a virus in a mammal. |
| 02/13/2003 | US20030032184 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030032005 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 02/13/2003 | US20030031737 Medicinal composition and method of using it |
| 02/13/2003 | US20030031694 Controlled release particles |
| 02/13/2003 | US20030031686 Exposing a source animal to an antigenic agent to elicit a T-cell mediated immune response, collecting an egg from the source that transfers cellular immunity to another animal in vivo |
| 02/13/2003 | US20030031683 Selecting for a strain of bacteria having an RpoS+ phenotype, inactivating mutations which render the strain attenutated, and a recombinant gene encoding the product |
| 02/13/2003 | US20030031682 Pathogens useful as vaccines for therapy and/ or prophylaxis |
| 02/13/2003 | US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 02/13/2003 | US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses |
| 02/13/2003 | US20030031659 For the treatment or prevention of a gastrointestinal infection caused by a pathogenic bacteria; for reducing insect and parasite populations in animal manure |
| 02/13/2003 | US20030031647 IFN-alpha and amantadine for treating hepatitis C |
| 02/13/2003 | US20030031644 For therapy of microbial infection in mammal |
| 02/13/2003 | US20030031631 Having surface tension, effective for therapy of respiratory systme disorders |
| 02/13/2003 | CA2808598A1 Antigenic polypeptides |
| 02/13/2003 | CA2780120A1 Immunologically significant herpes simplex virus antigens and methods for using same |
| 02/13/2003 | CA2494304A1 Materials and methods relating to improved vaccination strategies |
| 02/13/2003 | CA2456192A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2456007A1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation |
| 02/13/2003 | CA2455918A1 Hagfish cathelin-associated antimicrobial peptides and genes |
| 02/13/2003 | CA2455843A1 Therapeutic delivery compositions and methods of use thereof |
| 02/13/2003 | CA2455329A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 02/13/2003 | CA2454945A1 Use of oversulfated polysaccharides as inhibitors of hiv |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2453937A1 Antigenic polypeptides |
| 02/13/2003 | CA2453831A1 Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine |
| 02/13/2003 | CA2453410A1 Methods for treating prostatitis |
| 02/13/2003 | CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | CA2452524A1 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/12/2003 | EP1283267A1 Vector for analysing replication mechanism of rna virus and use thereof |
| 02/12/2003 | EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses |
| 02/12/2003 | EP1283211A2 L-Nucleosides for the treatment of hepatitis B-virus and Epstein-barr virus |
| 02/12/2003 | EP1283059A2 Therapeutic conjugates of toxins and drugs |
| 02/12/2003 | EP1283057A1 Cell proliferation inhibitors |
| 02/12/2003 | EP1283050A2 Improved therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products |
| 02/12/2003 | EP1283041A1 Pharmaceutical compositions containing HIV-protease inhibitors |
| 02/12/2003 | EP1282710A2 Fish vaccine against piscirickettsia salmonis |
| 02/12/2003 | EP1282703A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
| 02/12/2003 | EP1282699A2 Splice-region antisense composition and method |
| 02/12/2003 | EP1282692A2 Sentinel virus ii |
| 02/12/2003 | EP1282689A1 Specific inhibitors of ribosome recycling factor (rrf) |
| 02/12/2003 | EP1282646A2 Human monoclonal antibodies to dendritic cells |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282639A2 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 02/12/2003 | EP1282632A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 02/12/2003 | EP1282607A2 Prodrugs of hiv replication inhibiting pyrimidines |
| 02/12/2003 | EP1282606A2 Hiv replication inhibiting pyrimidines and triazines |
| 02/12/2003 | EP1282441A2 Treating t-cell mediated diseases by modulating dr6 activity |
| 02/12/2003 | EP1282435A2 Interleukin-1 inhibitors in the treatment of diseases |
| 02/12/2003 | EP1282427A2 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282422A1 Ciprofloxacin infusion solutions with improved storage life |
| 02/12/2003 | EP1282420A2 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/12/2003 | EP1282414A2 Felbamate derived compounds |
| 02/12/2003 | EP1282413A1 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 02/12/2003 | EP1094833B1 Oxidized thymosin beta 4 |
| 02/12/2003 | EP1049703B1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme |
| 02/12/2003 | EP1023294B1 Carbapenem derivatives and a preparation method thereof |